| __timestamp | Arrowhead Pharmaceuticals, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 581800000 |
| Thursday, January 1, 2015 | 57410147 | 671900000 |
| Friday, January 1, 2016 | 41454452 | 876700000 |
| Sunday, January 1, 2017 | 31690298 | 857900000 |
| Monday, January 1, 2018 | 52968505 | 822200000 |
| Tuesday, January 1, 2019 | 81048686 | 778200000 |
| Wednesday, January 1, 2020 | 128874979 | 512600000 |
| Friday, January 1, 2021 | 206342000 | 681000000 |
| Saturday, January 1, 2022 | 297307000 | 662200000 |
| Sunday, January 1, 2023 | 353188000 | 910700000 |
| Monday, January 1, 2024 | 505870000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Viatris Inc. and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Viatris consistently allocated a significant portion of its resources to R&D, peaking in 2023 with a 56% increase from its 2014 expenditure. Meanwhile, Arrowhead Pharmaceuticals showcased a remarkable growth story, with its R&D expenses surging by over 2,000% during the same period. This dramatic rise underscores Arrowhead's aggressive push towards pioneering new treatments.
Interestingly, the data for 2024 reveals a gap for Viatris, suggesting a potential shift in strategy or reporting. As these companies forge ahead, their R&D investments will undoubtedly shape the future of healthcare innovation.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Pfizer Inc. and Arrowhead Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Viatris Inc.: Strategic Focus on R&D Spending
GSK plc or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Viatris Inc. and Opthea Limited
Comparing Innovation Spending: Viatris Inc. and CRISPR Therapeutics AG
Viatris Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Arrowhead Pharmaceuticals, Inc. vs ImmunityBio, Inc.
R&D Spending Showdown: Arrowhead Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Research and Development Investment: Arrowhead Pharmaceuticals, Inc. vs Mesoblast Limited